The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData. [ + ]

Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time. [ + ]

You may be impressed to hear that there are iron objects in existence today that date back to the Bronze Age, but their meteorite origin is even more astonishing. [ + ]

Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells. [ + ]

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland. [ + ]

Animal studies undertaken at UTHealth have shown that the two seaweed extracts — known as fucoidans — have reduced tumour growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen. [ + ]

Supercomputer simulations have revealed the role of transport proteins called efflux pumps in creating drug resistance in bacteria — a breakthrough that could help improve drugs' effectiveness against life-threatening diseases and restore the efficacy of defunct antibiotics. [ + ]

MGC Pharmaceuticals has executed a binding definitive exclusive supply agreement with pharmaceutical wholesaler HL Pharma to bring its adult epilepsy product, CannEpil, to the Australian market in 2018. [ + ]

The ACCC has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia and Novartis Consumer Health Australasia, alleging they made false or misleading representations in the marketing of Voltaren Osteo Gel and Emulgel pain relief products. [ + ]

The National Health and Medical Research Council appears to be getting into the Christmas spirit early, announcing $640m to support Australia's health and medical researchers as well as an initiative to reduce the difference in funded rates between male and female lead investigators. [ + ]

UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases. [ + ]

Australian-listed global bio-therapeutics company CSL has confirmed a Phase 3 clinical trial for CSL112, the company's novel therapy for reduction of early recurrent cardiovascular events in heart attack survivors. [ + ]

Researchers from South Australia are leading what they believe to be a genomic revolution — and they couldn't have done it without the help of nine-year-old Angus Bond. [ + ]

More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance. [ + ]

Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack for the significant number of people presenting at hospital with chest pain. [ + ]